TNF blockers like Remicade, Enbrel, Humira, and Cimzia are big sellers for drug companies. The FDA's investigation is preliminary -- part of the agency's effort to let consumers know about potential problems earlier. This was partly a response to the Avandia controversy. Click the link for the FDA's Early Communication.